Table 2 Efficacy of CT lymph node MAD and/or serum SCC-Ag in judging retroperitoneal lymph node metastasis in patients with locally advanced cervical squamous cell carcinom
From: Assessment of retroperitoneal lymph node status in locally advanced cervical cancer
Group | Case | Pathological results | Accuracy (%) | Sensitivity(%) | Specificity (%) | Youden index | |
|---|---|---|---|---|---|---|---|
Positive | Negative | ||||||
CT lymph node MAD ≥1.0 cm + SCC-Ag ≥ 5.2 ng/mL | 24 | 24 | 0 | 75.71* | 58.54 | 100.0* | 0.59* |
CT lymph node MAD ≥1.0 cm | 40 | 33 | 7 | 72.09 | 66.0 | 80.56 | 0.47 |
SCC-Ag ≥ 5.2 ng/mL | 39 | 30 | 9 | 71.43 | 73.17 | 68.97 | 0.42 |